Skip to content

Establishment Labs ESTA Allowance for doubtful accounts

Allowance for doubtful accounts at other companies

Globus Medical logo
Globus MedicalGMED
Solventum logo
SolventumSOLV
Medtronic logo
MedtronicMDT
Boston Scientific logo
Boston ScientificBSX

Other financials

Income statement

See full
Revenue$59.9M+44.7%
Gross profit$42.3M+52.2%
Operating income-$6.5M+61.6%
Net income-$13.4M+35.4%
EPS (diluted)-$0.45+35.7%

Balance sheet

See full
Cash & equivalents$68.1M-1.6%
Total debt$252.7M+12.0%
Total equity$14.8M-61.7%
Total assets$351.0M+5.3%

Cash flow

See full
Operating cash flow-$4.3M+79.2%
CapEx$1.9M+146%
Free cash flow-$6.2M+71.3%

Valuation

See full
Market cap$2.56B+41.4%
Enterprise value$2.75B+38.7%
P/S11.2×+0.5×

Profitability

See full
Gross margin70.1%+3.7pp
Operating margin-12.4%-4.8pp
Net margin-19.1%-7.4pp
FCF margin-18.1%-6.6pp

Returns & leverage

See full
Return on equity-164%-17.8pp
Debt / equity17.1×+11.2×
Current ratio-0.4×

Where this comes from

Reported directly by Establishment Labs in its filing.

Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent.

The official record: Establishment Labs’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Establishment Labs's allowance for doubtful accounts.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Establishment Labs's allowance for doubtful accounts?
Establishment Labs (ESTA) reported allowance for doubtful accounts of $7M in Q1 2026.
How has Establishment Labs's allowance for doubtful accounts changed year-over-year?
Establishment Labs's allowance for doubtful accounts increased by 40.0% year-over-year, from $5M to $7M.
What is the long-term trend for Establishment Labs's allowance for doubtful accounts?
Over 5 years (2020 to 2025), Establishment Labs's allowance for doubtful accounts has grown at a 42.9% compound annual growth rate (CAGR), from $1.14M to $6.8M.